A photo of Eniolami Dosunmu.

Eniolami O. Dosunmu, MD


  • Pediatric Ophthalmologist, Division of Pediatric Ophthalmology
  • Assistant Professor, UC Department of Ophthalmology
  • Board Certified
Every single patient has a story, and I feel privileged to be a part of that story, for a little while. I listen to their stories, to learn what brought my patients and families to our practice. I work hard to ensure that patients have the best physical sight, so they can see their beautiful futures and live out their very best lives.

About

Biography

In my practice, as a pediatric eye doctor and surgeon, I am honored that families trust me with their children. I work hard to achieve the best outcomes for my patients and their families, and I make sure we have fun along the way.

As a pediatric ophthalmologist, I provide care and management for children with amblyopia, strabismus, CHARGE syndrome, pediatric cataracts, pediatric glaucoma (medical management), epidermolysis bullosa, Treacher Collins syndrome and other anterior segment disease processes.

I strive for excellence with each of my patients — they are the best part of what I do. I tell them, "I want you to have vision until you are 150 years old!"

Every single patient has a story, and I feel privileged to be a part of that story, for a little while. I listen to their stories, to learn what brought my patients and families to our practice. I work hard to ensure that patients have the best physical sight, so they can see their beautiful futures and live out their very best lives. I hope that when my patients and families look back over the story of their lives, our practice is a shining light in their memories.

I went to medical school planning to become a pediatrician. Shortly after my acceptance, doctors diagnosed my parent with eye disease. I decided to learn more about the cause of their vision loss in medical school. Along the way, my mentor, experiences, and the realization that I could still specialize in pediatrics while doing Ophthalmology, solidified my love for Ophthalmology — and the rest is history!

My research focuses on improving care for children with CHARGE syndrome, measurement of intraocular pressure (IOP) in children, amblyopia, and retinopathy of prematurity.

I am honored to be the recipient of several awards, including:

  • 2019 Medical Student Educator of the Year Award, Department of Ophthalmology, University of Cincinnati College of Medicine
  • 2013 American Association of Pediatric Ophthalmology and Strabismus Research Fellow Award for outstanding research in pediatric glaucoma
  • 2008 Leonard Tow Humanism in Medicine Award, The Ohio State University. This award recognizes graduating students and faculty members who demonstrate clinical excellence and outstanding compassion in care delivery; and who show respect for patients, families and healthcare colleagues
  • 2008 The Ohio State University College of Medicine Service Award, given to one graduating medical student for outstanding service work during their four years of medical school
  • 2008 Pediatric Glaucoma and Cataract Family Association Award, for research in pediatric glaucoma

In my free time, I love to read and cook. I also love superheroes.

Two secrets I want to share:

  1. One incredibly and extra-strong superpower is kindness (I should know, I do my best to make it mine!)
  2. I always have something on my person, every day, that is superhero related. I ask my patients to use their powerful eyes and their incredible brains to find it when they come in for their visits. And until then, I say, “May ‘The Force of Kindness’ be strong with you!”

Additional Languages

Native or Bilingual Proficiency

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Selected

Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants. Hartnett, ME; Wallace, DK; Dean, TW; Li, Z; Boente, CS; Dosunmu, EO; Freedman, SF; Golden, RP; Kong, L; Prakalapakorn, SG; et al. JAMA Ophthalmology. 2022; 140:337-344.

Selected

CHARGE syndrome without colobomas: Ophthalmic findings. Dosunmu, EO; Castleberry, KM. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics. 2020; 184:611-617.

Selected

Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity. Wallace, DK; Kraker, RT; Freedman, SF; Crouch, ER; Bhatt, AR; Hartnett, ME; Yang, MB; Rogers, DL; Hutchinson, AK; VanderVeen, DK; et al. JAMA Ophthalmology. 2020; 138:698-701.

Selected

Incidence and Etiology of Presumed Fourth Cranial Nerve Palsy: A Population-based Study. Dosunmu, EO; Hatt, SR; Leske, DA; Hodge, DO; Holmes, JM. American Journal of Ophthalmology. 2019; 185:110-114.

Selected

Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study. Wallace, DK; Kraker, RT; Freedman, SF; Crouch, ER; Hutchinson, AK; Bhatt, AR; Rogers, DL; Yang, MB; Haider, KM; VanderVeen, DK; et al. JAMA Ophthalmology. 2017; 135:654-656.

Selected

A comparison of Icare PRO and Tono-Pen XL tonometers in anesthetized children. McKee, EC; Ely, AL; Duncan, JE; Dosunmu, EO; Freedman, SF. Journal of AAPOS. 2015; 19:332-337.

Selected

Intraocular pressure in children: the effect of body position as assessed by Icare and Tono-Pen tonometers. Dosunmu, EO; Marcus, I; Tung, I; Thiamthat, W; Freedman, SF. American Journal of Ophthalmology. 2014; 158:1348-1352.e1.

Selected

The effect of repeated measurements and the use of topical anesthetic on rebound tonometry values in children. Dosunmu, EO; Marcus, I; Tung, I; Thiamthat, W; Freedman, SF. Journal of AAPOS. 2014; 18:619-621.

Selected

Anterior segment photography in pediatric eyes using the Lytro light field handheld noncontact camera. Marcus, I; Tung, IT; Dosunmu, EO; Thiamthat, W; Freedman, SF. Journal of AAPOS. 2013; 17:572-577.

Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity. Crouch, ER; Wallace, DK; Holmes, JM; Repka, MX; Steinkuller, PG; Freedman, SF; Prakalapakorn, SG; Jones, SK; Nasrazadani, DA; Cranford, AM; et al. JAMA Ophthalmology. 2020; 138:14-20.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey